drugset / Trial / NCT00503516

Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients

NCT00503516

Phase 2/3 Terminated 39 enrolled Rottapharm Spain
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to demonstrate the efficacy of megestrol acetate in the gain of body weight in patients with primary or mixed Dementia with a weight loss.

Timeline

Start
2007-06
Primary completion
2009-12
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Megestrol Acetate Other / unclassified 160 mg

Indications